PathoGene, Inc. is a seed-stage MedTech startup based in Los Angeles, with R&D in Monrovia, California. The company focuses on developing a sample-to-answer in vitro diagnostic device that detects and identifies all known microscopic human pathogens and their antimicrobial resistance profiles within six hours. Utilizing robotic automation, third-generation DNA and RNA sequencing, and cloud computing, PathoGene aims to revolutionize infectious disease diagnostics.
PathoGene has made significant strides in precision medicine by integrating advanced technologies to provide rapid and comprehensive diagnostic solutions. Their innovative approach has the potential to significantly impact patient outcomes and healthcare efficiency. The company is supported by a dedicated team of experts in biotechnology and medical diagnostics, driving forward its mission to enhance global health through cutting-edge diagnostic tools.
